Casi Pharmaceuticals China News and Activities

Casi Pharmaceuticals China is owned by Casi Pharmaceuticals.

Casi Pharmaceuticals is a company listed under the stock ticker CASI (US).

Casi Pharmaceuticals has a direct presence in 2 countries.

They are in:

• Pharmaceuticals67%
• Biotechnology33%

View the org chart displaying its 5 main executives

Most searched biographies at Casi Pharmaceuticals China

• Hai Huang, Global Chief Commercial Officer and General Manager
• Chunhua Wang, Chief Operating Officer
• Junping Chen, Medical Director

Popular executive movements at Casi Pharmaceuticals

• Wei-Wu He who was Executive Chairman of the Board, becomes Director  (posted on November 20 2025).
• Barbara Krebs-Pohl has joined the company as Non Executive Board Member  (posted on October 27 2025).
• James Huang has joined the company as Director  (posted on September 26 2025).

Create your alert
to follow the executive moves at Casi Pharmaceuticals China.

Casi Pharmaceuticals has 1,912 competitors including Sanofi (France), Eli Lilly (United States (USA)) and Moderna (United States (USA)).

Popular M&A news in Pharmaceuticals

• Laboratoire Servier has announced the acquisition of Edgewise Therapeutics  (posted on June 4 2026).
• Contraline has just announced a $93 Million fundraising (posted on June 3 2026).
• Hims & Hers has acquired Eucalyptus (posted on June 2 2026).

Popular contacts in Pharmaceuticals

• Joaquin Duato - Chief Executive Officer and Chairman of the Board at Johnson & Johnson
• Robert Ford - Chief Executive Officer and Chairman of the Board at Abbott
• Jonathan Leff - Director at Larimar Therapeutics

Learn more about the Pharmaceuticals industry

Press releases by Casi Pharmaceuticals China

Social media about Casi Pharmaceuticals China

• Casi Pharmaceuticals China on Wikipedia, Google News & Yahoo Finance
• Casi Pharmaceuticals China on LinkedIn, X (Twitter) & YouTube